GURUFOCUS.COM » STOCK LIST » Technology » Software » Newregen Inc (OTCPK:NREG) » Definitions » Ending Cash Position

Newregen (Newregen) Ending Cash Position : $0.00 Mil (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Newregen Ending Cash Position?

Newregen's Ending Cash Position for the quarter that ended in . 20 was $0.00 Mil.


Newregen Ending Cash Position Historical Data

The historical data trend for Newregen's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newregen Ending Cash Position Chart

Newregen Annual Data
Trend
Ending Cash Position

Newregen Semi-Annual Data
Ending Cash Position

Newregen Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Newregen's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Newregen's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00


Newregen Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Newregen's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Newregen (Newregen) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
200 Ashford Center North, Suite 160, Atlanta, GA, USA, 30338
Newregen Inc provides anti-aging and regenerative medical treatments. Its services include Hormone Replacement Therapy; Allograft Suspension (Stem Cell) Therapy; Longevity; Immunity; Weight Management and others.

Newregen (Newregen) Headlines

No Headlines